KALVISTA PHARMACEUTICALS, INC. COMMON STOCK (par value $0.001 per share) AT- THE-MARKET SALES AGREEMENTAt-the-Market Sales Agreement • July 13th, 2017 • KalVista Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 13th, 2017 Company Industry JurisdictionKalVista Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with BTIG, LLC (“BTIG” and, together with the Company, the “Parties”), as follows: